Prime Together Foundation selects 2023 grant recipients

The Foundation awarded a grant to 16 nonprofit organizations working toward equity and justice

December 13, 2023

The Prime Together Foundation recently awarded $138,600 in grants to 501(c)3 organizations that align with its mission to work together with communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger.

“It’s exciting to be able to give back to these 16 organizations that help make our communities a better place,” said Erin Feigal, senior vice president and chief human resources officer and Prime Together Foundation board chair. “I extend my gratitude to everyone who has supported the foundation over the past year, as you have helped make these grants possible.”

Among this year’s grant recipients are two organizations the Foundation previously supported –  Hennepin Healthcare Foundation and Living Well Disability Services – as well as 14 new organizations across seven states.

2023 Foundation grantees

Following is the full list of Prime Together Foundation grant recipients.

Prime Therapeutics and Magellan Rx (Prime/MRx) is passionate about helping local organizations combat inequalities and injustice. In 2020, company leaders and employees resolved to make a difference and create real change by creating a new foundation.

The Prime Together Foundation distributed its first cycle of grants in 2021. The Foundation continues to raise funds as it seeks to broaden its outreach and grow its impact.

​​​​​​Follow and consider supporting the Prime Together Foundation and its mission.

 

Related news

Stories

July 22, 2024

Introducing the latest issue of our medical and pharmacy benefit management report

The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care

Stories

July 18, 2024

Specialty drug trend forecasted to drop for employer groups, clinical experts say

Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend

Stories

July 16, 2024

Prime/Magellan Rx earns top score on the Disability Equality Index

For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion